Login to Your Account



Earnings Roundup


Monday, October 22, 2012

• Cubist Pharmaceuticals Inc., of Lexington, Mass., reported U.S. net product revenues for antibiotic Cubicin (daptomycin) totaling $208.3 million for the third quarter, up 12 percent over the same period in 2011.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription